While the original COVID-19 virus has mutated into less severe strains that typically cause milder infections in most healthy individuals, a significant group remains at risk of severe complications.
vaccines to include high-risk young and middle-age adults, CDC advisors have not yet moved to recommend the vaccine in these groups. In June, the FDA expanded the approval of GSK's RSV vaccine ...
Here's what high-risk groups infected with the HMPV virus may experience, as per the information provided by Max Healthcare: Young children: Infants and toddlers are vulnerable to serious ...